Capital Gp VII Llc Orbimed serves as Executive at Synthorx, Inc., where they oversee executive responsibilities. Since joining the company, Capital Gp VII Llc Orbimed has executed 63 insider transactions totaling $130.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 2, 2020 involved purchasing 200,000 shares valued at $5.0M.
Capital Gp VII Llc Orbimed currently holds 7,833,869 shares of Synthorx, Inc. (THOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp VII Llc Orbimed has been a net buyer of THOR stock. They have purchased $99.6M and sold $31.3M worth of shares.
Capital Gp VII Llc Orbimed's most recent insider trade was on Oct 2, 2020, when they purchased 200,000 shares at $25.00 per share.
Get notified when new Form 4 filings are submitted
| $25.00 |
| Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 148,922 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $6.0M | Purchase | 375,200 | $16.00 | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 744,612 | $N/A | Discretionary |
| Mar 16, 2020 | IMRA | $0 | Conversion | 1,594,902 | $N/A | Discretionary |
| Mar 12, 2020 | IMRA | $15.0M | Purchase | 937,500 | $16.00 | Discretionary |
| Mar 3, 2020 | PASG | $0 | Conversion | 3,721,552 | $N/A | Discretionary |
| Mar 3, 2020 | PASG | $0 | Conversion | 1,311,469 | $N/A | Discretionary |
| Mar 3, 2020 | PASG | $0 | Conversion | 541,002 | $N/A | Discretionary |
| Feb 28, 2020 | PASG | $6.7M | Purchase | 373,300 | $18.00 | Discretionary |
| Dec 11, 2018 | THOR | $15.0M | Purchase | 1,363,636 | $11.00 | Discretionary |
| Dec 11, 2018 | THOR | $0 | Conversion | 3,952,719 | $N/A | Discretionary |